Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision history updated: added v3.3.2 and removed v3.2.0; no changes to the study content.
    Difference
    0.0%
    Check dated 2025-11-25T11:48:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page. The study details and related information remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:09.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays sponsor-related entries such as the H. Lee Moffitt Cancer Center and Research Institute and includes a 'Helpful Links Provided by' section with a link to the Moffitt Clinical Trials site. This enhances access to sponsor resources and related trial information on the study page.
    Difference
    0.1%
    Check dated 2025-11-11T02:57:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No significant changes to the study details were detected between versions; any differences are likely cosmetic formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Update introduces newer date stamps and an estimated last-update label, while removing older date references and a prior last-update cue.
    Difference
    0.4%
    Check dated 2025-10-13T11:51:25.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an operational status notice about potential delays and updated links; replaces the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T06:38:06.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.